Tyrphostins .5. Potent inhibitors of platelet-derived growth factor receptor tyrosine kinase: Structure-activity relationships in quinoxalines, quinolines, and indole tyrphostins

被引:248
|
作者
Gazit, A
App, H
McMahon, G
Chen, J
Levitzki, A
Bohmer, FD
机构
[1] HEBREW UNIV JERUSALEM,ALEXANDER SILBERMAN INST LIFE SCI,DEPT BIOL CHEM,JERUSALEM,ISRAEL
[2] SUGEN INC,REDWOOD CITY,CA 94063
[3] UNIV JENA,GROWTH FACTOR SIGNAL TRANSDUCT MED FAC,MAX PLANCK SOC,RES GRP,D-07747 JENA,GERMANY
关键词
D O I
10.1021/jm950727b
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of 3-indoleacrylonitrile tyrphostins, 2-chloro-3-phenylquinolines, and 3-arylquinoxalines were prepared and tested for inhibition of platelet-derived growth factor receptor tyrosine kinase (PDGF-RTK) activity. The potency of the inhibitors was found to be quinoxalines > quinolines > indoles. Lipophilic groups (methyl, methoxy) in the 6 and 7 positions and phenyl at the 3 position of quinoxalines and quinolines were essential for potency, in contrast to the hydrophilic catechol group in tyrphostins active against EGFR kinase inhibition at different sites. The inhibitors showed selectivity for PDGF and were not active against EGF receptor and HER-2/c-ErbB-2 receptor.
引用
收藏
页码:2170 / 2177
页数:8
相关论文
共 50 条
  • [31] Effects of the indolocarbazole 3744W on the tyrosine kinase activity of the cytoplasmic domain of the platelet-derived growth factor β-receptor
    Uings, IJ
    Spacey, GD
    Bonser, RW
    CELLULAR SIGNALLING, 1999, 11 (02) : 95 - 100
  • [32] Use of multitarget tyrosine kinase inhibitors to attenuate platelet-derived growth factor signalling in lung disease
    Kanaan, Rana
    Strange, Charlie
    EUROPEAN RESPIRATORY REVIEW, 2017, 26 (146):
  • [33] Potent and selective inhibitors of platelet-derived growth factor receptor phosphorylation. 1. Synthesis, structure-activity relationship, and biological effects of a new class of quinazoline derivatives
    Matsuno, K
    Ichimura, M
    Nakajima, T
    Tahara, K
    Fujiwara, S
    Kase, H
    Ushiki, J
    Giese, NA
    Pandey, A
    Scarborough, RM
    Lokker, NA
    Yu, JC
    Irie, J
    Tsukuda, E
    Ide, S
    Oda, S
    Nomoto, Y
    JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (14) : 3057 - 3066
  • [34] Genetic Polymorphism on the Pharmacokinetics and Pharmacodynamics of Platelet-derived Growth Factor Receptor (PDGFR) Kinase Inhibitors
    Qian, Yi
    Yu, Lei
    Zhang, Xue-Hui
    Yuan, Zi-Qing-Yun
    Zhao, Ping
    Sun, Lu-Ning
    Wang, Yong-Qing
    CURRENT DRUG METABOLISM, 2018, 19 (14) : 1168 - 1181
  • [35] Tyrosine kinase activity of purified recombinant cytoplasmic domain of platelet-derived growth factor β-receptor (β-PDGFR) and discovery of a novel inhibitor of receptor tyrosine kinases
    Zaman, GJR
    Vink, PMF
    van den Doelen, AA
    Veeneman, GH
    Theunissen, HJM
    BIOCHEMICAL PHARMACOLOGY, 1999, 57 (01) : 57 - 64
  • [36] Identification of orally active, potent, and selective 4-piperazinylquinazolines as antagonists of the platelet-derived growth factor receptor tyrosine kinase family
    Pandey, A
    Volkots, DL
    Seroogy, JM
    Rose, JW
    Yu, JC
    Lambing, JL
    Hutchaleelaha, A
    Hollenbach, SJ
    Abe, K
    Giese, NA
    Scarborough, RM
    JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (17) : 3772 - 3793
  • [37] Synthesis and tyrosine kinase inhibitory activity of a series of 2-amino-8H-pyrido[2,3-d]pyrimidines:: Identification of potent, selective platelet-derived growth factor receptor tyrosine kinase inhibitors
    Boschelli, DH
    Wu, ZP
    Klutchko, SR
    Showalter, HDH
    Hamby, JM
    Lu, GH
    Major, TC
    Dahring, TK
    Batley, B
    Panek, RL
    Keiser, J
    Hartl, BG
    Kraker, AJ
    Klohs, WD
    Roberts, BJ
    Patmore, S
    Elliott, WL
    Steinkampf, R
    Bradford, LA
    Hallak, H
    Doherty, AM
    JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (22) : 4365 - 4377
  • [38] Discovery of Potent and Orally Bioavailable Platelet-Derived Growth Factor Receptor (PDGFR) Inhibitors for the Treatment of Osteosarcoma
    Chen, Xiaojing
    Liu, Lu
    Liu, Peng
    Chen, Yingying
    Lin, Dan
    Yan, Hao
    Yan, Qi
    Wang, Yi
    Qiu, Yinda
    Fang, Bo
    Huang, Huijing
    Qian, Jianchang
    Zhao, Yunjie
    Du, Zhou
    Zhang, Qianwen
    Li, Xiaokun
    Zheng, Xiaohui
    Liu, Zhiguo
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (07) : 5374 - 5391
  • [39] A NOVEL ENDOTHELIAL TYROSINE KINASE CDNA HOMOLOGOUS TO PLATELET-DERIVED GROWTH-FACTOR RECEPTOR CDNA
    SARZANI, R
    ARNALDI, G
    DEPIRRO, R
    MORETTI, P
    SCHIAFFINO, S
    RAPPELLI, A
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 186 (02) : 706 - 714
  • [40] Inhibition of obliterative bronchiolitis by platelet-derived growth factor receptor protein-tyrosine kinase inhibitor
    Kallio, E
    Koskinen, P
    Buchdunger, E
    Lemström, K
    TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) : 187 - 187